scholarly article | Q13442814 |
P50 | author | Takahiro Takazono | Q81109209 |
Tomoya Nishino | Q87801527 | ||
Taiga Miyazaki | Q88502855 | ||
Hiroshi Kakeya | Q88775740 | ||
Yoshitomo Morinaga | Q90329532 | ||
Shigeru Kohno | Q104013331 | ||
Yoshihiro Yamamoto | Q104139398 | ||
Koichi Izumikawa | Q109648459 | ||
Shintaro Kurihara | Q114454273 | ||
Yoshifumi Imamura | Q114454274 | ||
Katsunori Yanagihara | Q114454275 | ||
Takayoshi Tashiro | Q114454284 | ||
Misuzu Tsukamoto | Q114454289 | ||
Tomo Mihara | Q114454298 | ||
Akira Yasuoka | Q114454300 | ||
Mariko Mine | Q114454337 | ||
Shigeki Nakamura | Q124639537 | ||
P2860 | cites work | Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases | Q28264624 |
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma | Q28286684 | ||
Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 | ||
Chronic forms of pulmonary aspergillosis | Q34348164 | ||
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis | Q34514484 | ||
Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis | Q35636789 | ||
The invasive and saprophytic syndromes due to Aspergillus spp. | Q36235153 | ||
Role of bronchoalveolar lavage diagnostics in fungal infections | Q37449875 | ||
False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment | Q37597610 | ||
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid | Q37702655 | ||
Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance | Q37786504 | ||
Chronic necrotizing pulmonary aspergillosis: approach to management | Q41574360 | ||
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan | Q42924895 | ||
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. | Q44785839 | ||
Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome | Q45268727 | ||
Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. | Q51999514 | ||
Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. | Q53432792 | ||
Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis | Q53653935 | ||
Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspergillosis | Q259626 |
bronchoalveolar lavage | Q927148 | ||
P304 | page(s) | 811-817 | |
P577 | publication date | 2012-05-09 | |
P1433 | published in | Medical Mycology | Q6806389 |
P1476 | title | Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis | |
P478 | volume | 50 |
Q49546197 | Aspergillus in airway material : Ignore or treat? |
Q35142428 | Biomarkers for invasive aspergillosis: the challenges continue |
Q60364596 | Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings |
Q39028585 | Challenges in the management of chronic pulmonary aspergillosis |
Q39426203 | Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines |
Q47645128 | Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going? |
Q38168300 | Chronic pulmonary aspergillosis. |
Q38120032 | Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis |
Q40141118 | Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis. |
Q92177133 | Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis |
Q58586647 | Evaluation of Galactomannan Testing, the -Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis |
Q57749631 | Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis |
Q91950206 | Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients |
Q92457097 | Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis |
Q58769447 | Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis |
Q40283067 | Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis |
Q55489630 | Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. |